Literature DB >> 6799584

Demonstration of tyrosinase in the vitiligo skin of human beings by a sensitive fluorometric method as well as by 14C(U)-L-tyrosine incorporation into melanin.

I Husain, E Vijayan, A Ramaiah, J S Pasricha, N C Madan.   

Abstract

Tyrosinase activity (Monophenol, dihydroxyphenylalanine: oxygen oxidoreductase EC 1.14.18.1) in vitiligo and normal epidermal homogenates of skin from human beings was measured by estimating beta 3,4-dihydroxyphenylalanine (dopa) by a highly sensitive fluorometric method described in this paper. The tyrosine activity in the vitiligo skin was about 4 to 37% of corresponding normal skin. The activity of tyrosinase in normal human skin from different individuals and from different regions of the body was in the range of 4 to 140 picomoles of beta 3,4-dihydroxyphenylalanine formed per min/mg protein of epidermal homogenate. The enzyme from vitiligo and normal skin was severely inhibited by substance(s) of low molecular weight. The enzyme exhibits a lag of about 4 hr in the absence of added beta 3,4-dihydroxyphenylalanine and 1 hr in presence of 5 microM dopa. Tyrosinase from the normal and vitiligo skin was inhibited by excess concentration of tyrosine. The homogenates from vitiligo skin could synthesize melanin from C14(U)-L-Tyrosine. The rate of tyrosine incorporation into melanin by the epidermal homogenates is increased by 3,4-dihydroxyphenylalanine (dopa) disproportionate to its effect on tyrosinase activity. Based on the data presented in this paper it is concluded that melanocytes are present in the vitiligo skin. A tentative hypothesis is put forward to explain the lack of melanin synthesis by the vitiligo skin under in vivo conditions, although melanocytes are present.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6799584     DOI: 10.1111/1523-1747.ep12506603

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Human tyrosinase produced in insect cells: a landmark for the screening of new drugs addressing its activity.

Authors:  Stefano Fogal; Marcello Carotti; Laura Giaretta; Federico Lanciai; Leonardo Nogara; Luigi Bubacco; Elisabetta Bergantino
Journal:  Mol Biotechnol       Date:  2015-01       Impact factor: 2.695

2.  Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism.

Authors:  L B Giebel; R K Tripathi; K M Strunk; J M Hanifin; C E Jackson; R A King; R A Spritz
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

3.  pH-dependent interconversion of two forms of tyrosinase in human skin.

Authors:  R K Tripathi; C Chaya Devi; A Ramaiah
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

4.  A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.

Authors:  L B Giebel; R K Tripathi; R A King; R A Spritz
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

5.  A polymorphism of the human tyrosinase gene is associated with temperature-sensitive enzymatic activity.

Authors:  R K Tripathi; L B Giebel; K M Strunk; R A Spritz
Journal:  Gene Expr       Date:  1991-05

6.  Oxidation of monohydric phenol substrates by tyrosinase. An oximetric study.

Authors:  S Naish-Byfield; P A Riley
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

7.  Bacterial taxa predictive of hyperpigmented skins.

Authors:  Catherine Zanchetta; David Vilanova; Cyrille Jarrin; Amandine Scandolera; Emilie Chapuis; Daniel Auriol; Patrick Robe; Joran Dupont; Laura Lapierre; Romain Reynaud
Journal:  Health Sci Rep       Date:  2022-04-07

8.  Histidine residues at the copper-binding site in human tyrosinase are essential for its catalytic activities.

Authors:  Hyangsoon Noh; Sung Jun Lee; Hyun-Joo Jo; Hye Won Choi; Sungguan Hong; Kwang-Hoon Kong
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.